Skip to main content

US provides AstraZeneca with $1 billion for COVID-19 vaccine

AFP/Files
LONDON: British pharmaceuticals group AstraZeneca on Thursday said it had secured more than $1.0 billion from the United States to help fund production of its coronavirus vaccine.
AstraZeneca is partnering with University of Oxford to develop and distribute a vaccine being trialled in the UK.
It comes amid concerns that the United States could have a vaccine before other countries thanks to its large-scale funding of pharmaceutical companies around the world.
France has slammed Paris-based drugs giant Sanofi for suggesting the US would receive its vaccine first, as world leaders demand that the science should be shared among nations.
AstraZeneca on Thursday said it had "received support of more than $1.0 billion from the US Biomedical Advanced Research and Development Authorit for the development, production and delivery of the vaccine".
The company however added it was in contact with governments and international health institutions to ensure the vaccine is available globally.
AstraZeneca said it had concluded deals for the first 400 million doses of the vaccine — and has manufacturing capacity for one billion doses, with it hoping to begin deliveries in September.

'Accessible globally'

"AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organisations to make the University of Oxford's vaccine widely accessible around the world in an equitable manner," a statement said.
The company added it was "engaging with international organisations", including the World Health Organization, for the fair allocation and distribution of the vaccine around the world".
"AstraZeneca is also in discussions with governments around the world to increase access."
Britain this week pledged £84 million ($103 million, 93 million euros) to be split between researchers at Oxford University and Imperial College London to help finance a COVID-19 vaccine.
The UK government had already given £47 million.
Human trials of the vaccine developed by Oxford's Jenner Institute began last month, with hundreds of people in Britain volunteering to be part of the study.
The COVID-19 pandemic has killed more than 325,000 people worldwide, three-quarters of them in Europe and the United States, since breaking out in China last December.
More than five million have been infected globally by the pandemic, sparking a rush by pharmaceutical companies across the world to try and develop treatments and vaccines.
"This pandemic is a global tragedy and it is a challenge for all of humanity," AstraZeneca chief executive Pascal Soriot said in Thursday's statement.
"We need to defeat the virus together or it will continue to inflict huge personal suffering and leave long-lasting economic and social scars in every country around the world.;



Comments

Popular posts from this blog

Donald Trump or Joe Biden? What will change for Asean after the US election?

https://twitter.com/mujeebsubhan786 https://web.facebook.com/mdmujeeb.subhan.5

Global coronavirus cases cross 40 million: Reuters tally

Worldwide coronavirus cases crossed 40 million on Monday, according to a Reuters tally, as the onset of winter in the northern hemisphere fuelled a resurgence in the spread of the disease. The Reuters tally is based on official reporting by individual countries. Experts believe the true numbers of both cases and deaths are likely much higher, given deficiencies in testing and potential under-reporting by some countries. The Reuters data shows the pace of the pandemic continues to pick up. It took just 32 days to go from 30 million global cases to 40 million, compared with the 38 days it took to get from 20 to 30 million, the 44 days between 10 and 20 million, and the three months it took to reach 10 million cases from when the first cases were reported in Wuhan, China, in early January. Record one-day increases in new infections were seen at the end of last week, with global coronavirus cases rising above 400,000 for the first time. There were an average of around 347,000 c...

Russia-Ukraine war reaches 100 days: By the numbers

The invasion of Ukraine has lasted 100 days, with no end yet in sight as Russia and Ukraine continue to fight for control of eastern Ukraine. Russia maintains that it is conducting a "special operation" in its neighboring country, and the "operation" has taken a significant toll on the Ukrainian people. Nearly 15 million people have reportedly fled their homes since the invasion started, according to the latest data from the United Nations Office for the Coordination of Humanitarian Affairs (OCHA). The data indicates that around 6.8 million Ukrainian residents have headed for neighboring countries while an additional (estimated) 8 million remain displaced within the country itself. The latest count shows that 3,627,178 people went to Poland, 989,357 went to Romania, 971,417 went to Russia, 682,594 went to Hungary, 479,513 went to Moldova, 461,164 went to Slovakia and 30,092 went to Belarus. Those numbers continue to climb. Most of the refugees are women and ch...